Conor Gruber

6PUBLICATIONS

75CO-AUTHORS

Nanotoxicology, health and safetyGene and molecular therapyInfant and child healthAutoimmunityInnate immunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jul 01, 2026

Functional studies in a neonate with a DOCK11 VUS guide clinical care.

|May 29, 2026

STAT2 R148 variant: A 16th-century founder mutation and clinical response to high-dose JAK inhibitor therapy.

|Jan 29, 2026

Markers of immune dysregulation in pediatric patients with severe bronchiolitis.

Katherine Hickey, Conor Gruber, Sofija Buta-Panov

|Apr 02, 2024

Individuals with JAK1 variants are affected by syndromic features encompassing autoimmunity, atopy, colitis, and dermatitis.

Michael E Horesh, Marta Martin-Fernandez, Conor Gruber

|Mar 08, 2022

A partial form of inherited human USP18 deficiency underlies infection and inflammation.

Marta Martin-Fernandez, Sofija Buta, Tom Le Voyer

|Jan 16, 2020

JAK Inhibitor Therapy in a Child with Inherited USP18 Deficiency.

Fahad Alsohime, Marta Martin-Fernandez, Mohamad-Hani Temsah

Pageof 1

Frequent Collaborators

5 joint publications

Dusan Bogunovic

4 joint publications

Sofija Buta-Panov

3 joint publications

Jean-Laurent Casanova

3 joint publications

Jacinta Bustamante

3 joint publications

Jérémie Rosain

2 joint publications

Marta Martin-Fernandez

Tom Le Voyer

Fatima Ailal

Aziz Bousfiha

Zhi Li

Frequent Collaborators

5 joint publications

Dusan Bogunovic

4 joint publications

Sofija Buta-Panov

3 joint publications

Jean-Laurent Casanova

3 joint publications

Jacinta Bustamante